2 completed, 1 withdrawn. 2 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Jean Yuh Tang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer Arsenic Trioxide, Itraconazole, Laboratory Biomarker Analysis - Skin Basal Cell Carcinoma | Early Phase 1 | Withdrawn | Jean Yuh Tang | 2020-12-01 | 2020-10-22 | |
| Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients VPD-737, Placebo - Epidermolysis Bullosa, Pruritus | Phase 2 | Completed | Jean Yuh Tang | 14 | 2016-08-31 | 2020-03-23 |
| Topical Itraconazole in Treating Patients With Basal Cell Cancer Itraconazole, Placebo - Skin Basal Cell Carcinoma | Early Phase 1 | Completed | Jean Yuh Tang | 9 | 2016-05-05 | 2019-04-11 |
Carcinoma, Basal Cell (2) · Epidermolysis Bullosa (1) · Pruritus (1)
Itraconazole (2) · Arsenic Trioxide (1) · arsenous acid (1) · serlopitant (1)
United States (2)
Anthony Oro (1) · Jean Tang (1) · Jean Tang, MD, PhD (1)
P30CA124435 (1)